Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current gene therapy

Showing results (31-40 of 1,146) with videos related to

Pageof 115
Sort By:
Current Gene Therapy|December 8, 2004
Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transductionR Tomanin, M Scarpa
Current Gene Therapy|December 8, 2004
Vaccinia viral/retroviral chimeric vectorsF G Falkner, G W Holzer
Current Gene Therapy|December 8, 2004
Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challengesCaroline Beck, Hidetaka Uramoto, Jan Borén, et al.
Current Gene Therapy|December 8, 2004
Alternative gene therapy strategies for the repair of craniofacial bone defectsJuan Dai, A B M Rabie, U Hagg, et al.
Current Gene Therapy|January 11, 2005
Antibody engineering, virus retargeting and cellular immunotherapy: one ring to rule them all?Laura Sanz, Jian Qiao, Richard G Vile, et al.
Current Gene Therapy|December 20, 2003
The uses of poxviruses as vectorsA Vanderplasschen, P-P Pastoret
Current Gene Therapy|March 23, 2004
Exploiting internal ribosome entry sites in gene therapy vector designS M Ngoi, A C Chien, C G L Lee
Current Gene Therapy|March 23, 2004
Replicative oncolytic herpes simplex viruses in combination cancer therapiesDawn E Post, Giulia Fulci, E Antonio Chiocca, et al.
Current Gene Therapy|March 23, 2004
Can the use of HIV-1 derived gene transfer vectors for clinical application be justified?M Fuller, D S Anson
Current Gene Therapy|March 23, 2004
TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapyW Liu, D R Wang, Y L Cao
Pageof 115

Showing results (31-40 of 1,146) with videos related to

Sort By:
Pageof 115
Current Gene Therapy|December 8, 2004
Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transductionR Tomanin, M Scarpa
Current Gene Therapy|December 8, 2004
Vaccinia viral/retroviral chimeric vectorsF G Falkner, G W Holzer
Current Gene Therapy|December 8, 2004
Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challengesCaroline Beck, Hidetaka Uramoto, Jan Borén, et al.
Current Gene Therapy|December 8, 2004
Alternative gene therapy strategies for the repair of craniofacial bone defectsJuan Dai, A B M Rabie, U Hagg, et al.
Current Gene Therapy|January 11, 2005
Antibody engineering, virus retargeting and cellular immunotherapy: one ring to rule them all?Laura Sanz, Jian Qiao, Richard G Vile, et al.
Current Gene Therapy|December 20, 2003
The uses of poxviruses as vectorsA Vanderplasschen, P-P Pastoret
Current Gene Therapy|March 23, 2004
Exploiting internal ribosome entry sites in gene therapy vector designS M Ngoi, A C Chien, C G L Lee
Current Gene Therapy|March 23, 2004
Replicative oncolytic herpes simplex viruses in combination cancer therapiesDawn E Post, Giulia Fulci, E Antonio Chiocca, et al.
Current Gene Therapy|March 23, 2004
Can the use of HIV-1 derived gene transfer vectors for clinical application be justified?M Fuller, D S Anson
Current Gene Therapy|March 23, 2004
TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapyW Liu, D R Wang, Y L Cao
Pageof 115